Compounds > 1,4-phenylenebis(methylene)selenocyanate
Page last updated: 2024-11-05

1,4-phenylenebis(methylene)selenocyanate and Benign Neoplasms

1,4-phenylenebis(methylene)selenocyanate has been researched along with Benign Neoplasms in 2 studies

1,4-phenylenebis(methylene)selenocyanate: structure given in first source; inhibits DMBA-induced carcinogenesis by inhibiting DMBA-DNA adduct formation

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shimada, T1
Murayama, N1
Tanaka, K1
Takenaka, S1
Guengerich, FP1
Yamazaki, H1
Komori, M1

Other Studies

2 other studies available for 1,4-phenylenebis(methylene)selenocyanate and Benign Neoplasms

ArticleYear
Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.
    Chemical research in toxicology, 2011, Aug-15, Volume: 24, Issue:8

    Topics: Animals; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Binding Sites; Biocatalysis; Catalyti

2011
Clinical development plan: 1,4-penylenebis(methylene)selenocyanate.
    Journal of cellular biochemistry. Supplement, 1996, Volume: 26

    Topics: Animals; Anticarcinogenic Agents; Clinical Trials, Phase I as Topic; Dogs; Drug Approval; Female; Hu

1996